Brooke N. McLain is an associate in Sterne Kessler’s Trial & Appellate Practice Group. She concentrates her practice in the area of patent litigation, including matters before federal district courts and the United States International Trade Commission. Brooke has experience handling matters in areas such as ANDA pharmaceutical litigation and the automotive industry.

While attending J. Reuben Clark Law School, Brooke served for two years as an articles editor for the BYU Law Review. She was a Judicial Extern for the Honorable Judge David Nuffer of the United States District Court for the District of Utah. Brooke also participated in the Giles Sutherland Rich Memorial Moot Court competition, the Trial Advocacy Team, the Health Law Society, and the Center for Conflict Resolution.

Prior to law school, Brooke received her B.A. in Molecular and Cellular Biology from Harvard, focusing her studies on genetics. Her wet lab research focused on C. elegans, drug interactions, and fluorescent microscopy.

  • J.D., J. Reuben Clark Law School
  • B.A., Molecular and Cellular Biology, Harvard University

  • District of Columbia
  • Virginia

Related News & Insights

From Brooke N. McLain

U.S. IP Update

May 20, 2026

U.S. IP Update – May 2026

Multiple Authors

Articles

April 9, 2026

Key Provisions of the Remedy Act and Their Impact on Hatch‑Waxman Litigation

Sterne, Kessler, Goldstein & Fox Multiple Authors

Firm News

March 11, 2026

Sterne Kessler Secures Victory for SV3 (Mi-Pod) in Section 337 Investigation

Sterne, Kessler, Goldstein & Fox Multiple Authors

Reports

January 23, 2026

2025 AI Intellectual Property Year in Review: Analysis & Trends

Sterne, Kessler, Goldstein & Fox Multiple Authors

Reports

January 16, 2026

2025 ITC Section 337 Year in Review: Analysis & Trends

Sterne, Kessler, Goldstein & Fox Multiple Authors

Client Alert

August 14, 2025

IP Hot Topic: Federal Circuit Leaves Open Questions Regarding Jurisdiction of Sanction Decisions

Brooke N. McLain, Uma N. Everett

Client Alert

April 21, 2025

IP Hot Topic: The Federal Circuit Confirms That Commission Cannot Be Compelled to Issue Sua Sponte Order

Brooke N. McLain, Uma N. Everett

Firm News

March 25, 2025

Sterne Kessler’s Client RoboticVISION Tech, Inc. Obtains Favorable Settlement

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

November 20, 2024

RJ Reynolds Loses Early Exclusion Bid in ITC Vape IP Case

Law360 Multiple Authors

Firm News

November 19, 2024

Sterne Kessler Secures U.S. International Trade Commission Win for SV3 in Unfair Importation Case Brought by RJ Reynolds

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

February 28, 2024

Jury Awards Wirtgen $12.9M Against Caterpillar in Milling Machine Lawsuit

Equipment World Multiple Authors

Firm News

February 27, 2024

Sterne Kessler and Patterson IP Law Team Up to Secure $12.9M Wirtgen Win Over Caterpillar

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

February 27, 2024

Caterpillar Owes Deere $13 Million in Road-Milling Patent Trial

Bloomberg Law Multiple Authors

In the News

February 26, 2024

Caterpillar to Pay Wirtgen $12.9M in Damages After Patent Battle

Construction Briefing Multiple Authors

In the News

February 26, 2024

Wirtgen Triumphs Over Caterpillar in $12.9 Million Patent Infringement Verdict

BNN Multiple Authors

In the News

February 23, 2024

Deere’s Wirtgen Wins $12.9 mln from Caterpillar in Road-Construction Patent Trial

Reuters Multiple Authors

Articles

February 14, 2024

Rule and Procedural Developments at the ITC in 2023

Sterne, Kessler, Goldstein & Fox Daniel E. Yonan, Brooke N. McLain

Reports

February 14, 2024

2023 ITC Section 337 Year in Review: Analysis & Trends

Sterne, Kessler, Goldstein & Fox Multiple Authors

Firm News

February 14, 2024

Sterne Kessler Publishes 2023 ITC Section 337 Year in Review: Analysis & Trends Report

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

January 9, 2024

Teva Pharmaceuticals Successfully Defends Against Allegations of Patent Infringement

Parsippany Focus Multiple Authors

In the News

January 3, 2024

Teva Defeats Infringement Claims on Endocrine Drug

New Jersey Law Journal Multiple Authors

Firm News

January 3, 2024

Sterne Kessler Secures Non-Infringement Win for Teva Pharmaceuticals

Sterne, Kessler, Goldstein & Fox Multiple Authors

Firm News

August 29, 2023

U.S. District Court Affirms Immigrant Children’s Constitutional Rights

Sterne, Kessler, Goldstein & Fox Multiple Authors

In the News

March 9, 2022

Acer Ends 4G Patent Lawsuit Against Volkswagen in U.S. Court

Reuters Multiple Authors